isospaglumic acid has been researched along with Brain Ischemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bzdega, T; Gehl, LM; Neale, JH; Olszewski, RT; Wroblewska, B | 1 |
Ebinger, G; Hachimi-Idrissi, S; Michotte, Y; Sarre, S; Van Hemelrijck, A | 1 |
Bhardwaj, A; Britton, P; Harukuni, I; Hurn, PD; Jackson, PF; Lu, XC; Potter, BM; Robinson, MB; Slusher, BS; Thomas, AG; Tortella, FC; Traystman, RJ; Vornov, JJ; Wozniak, KM; Yudkoff, M | 1 |
1 review(s) available for isospaglumic acid and Brain Ischemia
Article | Year |
---|---|
The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.
Topics: Amyotrophic Lateral Sclerosis; Animals; Brain Ischemia; Diabetic Neuropathies; Dipeptides; Glutamate Carboxypeptidase II; Humans; Pain; Protease Inhibitors; Schizophrenia | 2005 |
2 other study(ies) available for isospaglumic acid and Brain Ischemia
Article | Year |
---|---|
Neuroprotective effect of N-acetyl-aspartyl-glutamate in combination with mild hypothermia in the endothelin-1 rat model of focal cerebral ischaemia.
Topics: Amino Acids; Animals; Blood-Brain Barrier; Brain Ischemia; Dipeptides; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Endothelin-1; Hypothermia; Male; Microdialysis; Neuroprotective Agents; Rats; Rats, Wistar; Time Factors; Xanthenes | 2005 |
Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.
Topics: Animals; Brain Ischemia; Carboxypeptidases; Culture Techniques; Dipeptides; Disease Models, Animal; Drug Tolerance; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Glutamic Acid; Ischemic Attack, Transient; Mice; Mice, Inbred ICR; Neuroprotective Agents; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Stroke | 1999 |